ABC transporters have been shown to pump substrates, including GEM, out of tumor cells via an ATP-dependent mechanism, reducing effective drug concentration and thereby weakening the antitumor effect of chemotherapeutic drugs (43). The gene discussed is ABCG2; the disease is neoplasm.